Category: News

Genomic Alterations and Targeted Treatment by Race in Metastatic Breast Cancer Emily Podany, MD, Hematology-Oncology Fellowship Program, Fellow Wellness Leader, WashU Division of Oncology, was recently spotlighted in JNCCN360 for her work on Genomic Alterations and Targeted Treatment by Race in Metastatic Breast Cancer. The study used a multi-institution consortium database that includes both clinical […]

Congratulations to Division Chief of General Medicine & Geriatrics, Dr. Bradley Evanoff, on his journalistic publication.

Kudos to everyone who helped make the 2nd Annual Glomerular Disease Symposium: An Update on Disease Mechanisms and Management, held September 6 – 7, 2024, a success.  The event was organized and chaired by WashU Nephrology’s Tingting Li, MD, MSCI, with the support of the planning committee members Michelle Bloom, BSN, RN, Reena Gurung, MD, Nidia Messias, MD, and Morgan Schoer, MD, and Continuing Medical […]

Crucial intersection of oncology and HIV research, with insights for clinical practice Thomas A. Odeny, MD, MPH, PhD, Assistant Professor of Medicine at WashU Division of Medical Oncology, leads the Global Oncology Initiative. He recently was published in Science Direct with new insights into HIV and cancer research. Dr. Odeny’s research focuses on applying implementation […]

Giulia Petrone, MD, WashU Hematology/Oncology Fellow, study, “Clinical and Therapeutic Implications of Clonal Hematopoisis” was recently published in Annual Review of Genomics and Human Genetics, Volume 25, 2024. Clonal Hematopoiesis (CH) is a condition in which hematopoietic stem and progenitor cells acquire the same somatic mutations, leading to the expansion of these mutated cells. The […]

Over 80% of patients achieved control within a month, sustained at six months A new study, that Mark Huffman, MD, MPH, William Bowen Professor of Medicine, Co-Director, Global Health Center, WashU Cardiovascular Division, who is a co-author, shows that a treatment plan containing low doses of three antihypertensive drugs in a single pill – known […]

In March, Alexander M. Markov, MD; Sina Jasim, MD, MPH; and Jennifer Powers Carson, PhD had their article titled “A Puzzling Case of Elevated Parathyroid Hormone,” published by The Journal of Applied Laboratory Medicine.

Having a severe case of Covid-19 appears to be linked with an increased risk of subsequent mental illness, including depression and anxiety disorders, and a new study finds that the association is strongest among people who were not vaccinated against the disease.

The Ferraro Lab led by Francesca Ferraro, MD, PhD, Assistant Professor of Medicine, WashU Division of Oncology has recently made significant contribution in understanding the role of MYC mutations in the development of Acute Myeloid Leukemia (AML). Dr. Ferraro’s lab publication, titled “Missense Mutations in Myc Box I Influence Nucleocytoplasmic Transport to Promote Leukemogenesis,” is […]

Assistant Professor of Medicine Dr. Ali Javaheri was featured in an article titled “Translating metabolic and cardiovascular research into effective treatments: What’s next?” In a special 50th Anniversary edition of the journal Cell.

Healthcare innovation is accelerating at an unprecedented pace, and cardiology is on the brink of transformative change using new forms of remote monitoring and artificial intelligence (AI). 

Researchers at Washington University School of Medicine in St. Louis have shown how brain tumors evolve in response to therapy, helping describe how such cancers develop treatment resistance that leads to the high mortality rate characteristic of this cancer. Only 5% of patients survive five years after diagnosis with the most aggressive brain cancers.  

Raja Dandamudi, MD, an assistant professor of pediatrics, Vikas Dharnidharka, MD, a professor of pediatrics, and Tarek Alhamad, MD, a professor of medicine at Washington University School of Medicine in St. Louis, contributed to a large study that identified a novel way of detecting signs of organ rejection. The international team found that DNA shed from dying […]

Two studies from Washington University School of Medicine in St. Louis focused on breast cancer and pancreatic cancer suggest that specific types of senescent cells — cells that have stopped dividing and drive inflammation — may play important roles in suppressing the immune system and allowing such tumors to grow unchecked. 

The Society of Hospital Medicine has several publications, including their monthly newsletter, ‘The Hospitalist.’ For the month of August 2024, Dr. Mark Williams was featured on the cover of the newsletter, and was interviewed for an article titled, “Managing the Long-term Physical Effects of Being a Hospitalist.”

Study in hamsters indicates vaccines targeting nose, mouth may be key to controlling spread of respiratory infections

Marlie Maestas, a fifth-year graduate student in the Millman Lab, recently published her first first-authorship in Nature Communications. The study, titled Identification of unique cell type responses in pancreatic islets to stress, detailed the responses of different pancreatic islet cell types to endoplasmic reticulum and inflammatory stress.